Julie Rubinstein, President and COO at Adaptive Biotechnologies Corp (ADPT), sold 69,061 shares at $14.33 ($991K) on 2026-04-06, disclosed to the SEC on 2026-04-08.
Scheduled sale ($991k) by President and COO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.33 | 19,060 | $273K | 27.6% |
| 2 | $13.56 | 19,060 | $258K | 26.1% |
| 3 | $14.83 | 30,841 | $457K | 46.2% |
| 4 | $15.48 | 100 | $2K | 0.2% |
| Total | $14.34 avg | 69,061 | $991K | 100% |
| Filing → |
| ADPT | SELL | 2026-10-05 | $1.0M | — | Filing → |
| ADPT | SELL | 2026-04-29 | $271K | — | Filing → |
| ADPT | SELL | 2026-04-24 | $798K | — | Filing → |